Nine Month Profit Rebound Change The Bull Case For STAAR Surgical Stock?
The top 5 analyst questions from STAAR Surgical’s Q3 2026 earnings call
STAAR Surgical (STAA) Could Be 10% Undervalued As Earnings Reset The Valuation Debate
STAAR Surgical (STAA) Q3 2026 Earnings Call Transcript
STAAR Surgical Company Q3 2026 Earnings Call Summary
Staar Surgical Co (STAA) (Q3 2026) Earnings Call Highlights: Record Nine-Month Revenue, Strong ...
What STAAR Surgical (STAA) Said on Its Q3 Earnings Call
STAAR Surgical Company (STAA) Q3 2026 Earnings Call Transcript
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates
Staar Surgical: Q3 Earnings Snapshot
STAAR Surgical (NASDAQ:STAA) reports strong Q3 2026
STAAR Surgical Reports Third Quarter 2026 Results
Staar Surgical Q3 2026 Earnings Call Transcript
STAAR Surgical Announces $50M Buyback Plan
Staar Surgical Q3 EPS $0.11 Beats $0.05 Estimate, Sales $83.411M Beat $78.762M Estimate
Is STAAR Surgical (STAA) Trading At A Discount After The Investigation?
STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
STAAR Surgical to Participate in Upcoming Investor Conferences
STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
Will New Business Development VP Hire and Lens Expansion Strategy Change STAAR Surgical's (STAA) Narrative
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.